المؤلفون: Czarnecka, Anna M, Skoczylas, Jacek, Bartnik, Ewa, Świtaj, Tomasz, Rutkowski, Piotr

المصدر: Cancer Management & Research; Jul2023, Vol. 15, p615-623, 9p

مصطلحات موضوعية: SMOOTH muscle tumors, SURGICAL margin, CELL tumors, ADULTS, SMOOTH muscle, MTOR inhibitors

المؤلفون: Meredith, Luke, Chao, Timothy, Nevler, Avinoam, Mallick, Atrayee Basu, Singla, Rajan, McCue, Peter, Bowne, Wilbur, Jiang, MD, PhD, Wei

المصدر: Kimmel Cancer Center Faculty Papers

مصطلحات موضوعية: humans, male, MTOR inhibitors, mutation, perivascular epithelioid cell neoplasms, sarcoma, sirolimus, TOR serine-threonine kinases, Genomics, Medical Pathology, Oncology, Surgery

وصف الملف: application/pdf

العلاقة: https://jdc.jefferson.edu/kimmelccfp/99Test; https://jdc.jefferson.edu/context/kimmelccfp/article/1099/viewcontent/Rare_Metastatic_Mesenteric_Malignant_PEComa.pdfTest; https://jdc.jefferson.edu/context/kimmelccfp/article/1099/filename/0/type/additional/viewcontent/Supplemental_Figure.docxTest

الإتاحة: https://jdc.jefferson.edu/kimmelccfp/99Test
https://jdc.jefferson.edu/context/kimmelccfp/article/1099/viewcontent/Rare_Metastatic_Mesenteric_Malignant_PEComa.pdfTest
https://jdc.jefferson.edu/context/kimmelccfp/article/1099/filename/0/type/additional/viewcontent/Supplemental_Figure.docxTest

المصدر: Drug Week; 1/5/2024, p418-418, 1p

مصطلحات موضوعية: RENAL cell carcinoma, RENAL cancer, NEUROBLASTOMA, CHILDHOOD cancer, MTOR inhibitors

مصطلحات جغرافية: BALTIMORE (Md.)

الشركة/الكيان: JOHNS Hopkins University

المؤلفون: Rosemeire Simone Dellacrode Giovanazzi, Walace de Souza Pimentel, João Carlos Marchiori de Claudio, Thulssa Auxiliadora Gomes Medeiros dos Santos, Suelen Alves Creste Martins da Costa, Regimar Carla Machado, Ana Lúcia Gargione Galvão de Sant'Anna, Camila Bomfim von Jakitsch, Nelson Américo Hossne Junior, João Nelson Rodrigues Branco, Puri Girones, Andressa Rodrigues de Souza

المصدر: Transplantation Proceedings. 53:3056-3064

مصطلحات موضوعية: Graft Rejection, Oncology, medicine.medical_specialty, medicine.medical_treatment, Calcineurin Inhibitors, Renal function, law.invention, Randomized controlled trial, law, Internal medicine, medicine, Humans, Lung transplantation, Adverse effect, Sirolimus, Transplantation, Lung, business.industry, TOR Serine-Threonine Kinases, Graft Survival, Immunosuppression, MTOR Inhibitors, Kidney Transplantation, Calcineurin, medicine.anatomical_structure, Meta-analysis, Surgery, business, Immunosuppressive Agents, Lung Transplantation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96138adbc3c46968892e082ac48c3a82Test
https://doi.org/10.1016/j.transproceed.2021.09.019Test

المؤلفون: Ashish Verma, Roli Purwar, Tarun Kumar, Kishan Soni, Manoj Pandey, Mridula Shukla

المصدر: World journal of surgical oncology. 20(1)

مصطلحات موضوعية: business.industry, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Perivascular Epithelioid Cell Neoplasms, TOR Serine-Threonine Kinases, TFE3, Middle Aged, Discovery and development of mTOR inhibitors, Immunohistochemistry, Perivascular Epithelioid Cell, Oncology, Cancer research, Biomarkers, Tumor, Medicine, Humans, Surgery, Female, business, Complete response

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1afa8e3c7bbc942137fd2092e3bbd9eTest
https://pubmed.ncbi.nlm.nih.gov/35232443Test

المؤلفون: Xiulian Li, Xuehong Ran, Wei Wu, Lida Wang, Huo Da, Zhixin Sheng

المصدر: The breast journalREFERENCES. 26(9)

مصطلحات موضوعية: business.industry, Receptor, ErbB-2, TOR Serine-Threonine Kinases, Network Meta-Analysis, MEDLINE, Breast Neoplasms, Phosphatidylinositol 3-Kinases, Discovery and development of mTOR inhibitors, medicine.disease, Breast cancer, Oncology, Meta-analysis, Internal Medicine, medicine, Cancer research, Humans, Surgery, Female, Receptor, business, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::643655eb39705315e6964e1787e95854Test
https://pubmed.ncbi.nlm.nih.gov/32037589Test

المؤلفون: D. N. Suslov

المصدر: Transplantologiâ, Vol 10, Iss 1, Pp 42-49 (2018)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Immunology, immunosuppressive therapy, Transplanted kidney, Rational use, Internal medicine, m-tor inhibitors, medicine, Immunology and Allergy, individual adaptation, Kidney transplantation, Transplantation, Life span, business.industry, Cancer, medicine.disease, Discovery and development of mTOR inhibitors, accessibility, surgical procedures, operative, Renal allograft, Medicine, Surgery, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::717cd38ccf12723530bb25235d67ad9cTest
https://doi.org/10.23873/2074-0506-2018-10-1-42-49Test

المؤلفون: Jennifer J. Wheler, Apostolia Maria Tsimberidou, Aung Naing, Vivek Subbiah, Siqing Fu, Razelle Kurzrock, Susan Kambrick, Bonnie S. Glisson, Sarina Anne Piha-Paul, Ralph Zinner, Xiaochun Liu, George R. Blumenschein, David S. Hong, Merrill S. Kies

المصدر: Oncotarget
Oncotarget, vol 7, iss 17
Liu, X; Kambrick, S; Fu, S; Naing, A; Subbiah, V; Blumenschein, GR; et al.(2016). Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus. ONCOTARGET, 7(17), 23227-23238. doi: 10.18632/oncotarget.7594. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/3xx7q8fsTest

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Maximum Tolerated Dose, Bevacizumab, Oncology and Carcinogenesis, Cetuximab, and over, bevacizumab, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Internal medicine, temsirolimus, Antineoplastic Combined Chemotherapy Protocols, 80 and over, medicine, Humans, PI3K/AKT/mTOR pathway, Aged, Aged, 80 and over, Sirolimus, Hematology, business.industry, Cancer, solid tumors, Middle Aged, Prognosis, medicine.disease, Discovery and development of mTOR inhibitors, Temsirolimus, Surgery, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, business, Hypophosphatemia, Research Paper, Follow-Up Studies, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a46d89e727927f9fdb71c1ce8e76522Test
https://doi.org/10.18632/oncotarget.7594Test

المؤلفون: Maria Rios, Marta Jimenez, Jacques Bonneterre, Bénédicte Elena-Herrmann, Olivier Tredan, Elodie Jobard, Véronique Diéras, Celine Mahier Ait-Oukhatar, Monica Arnedos, Thomas Bachelot, Jean-Louis Merlin, Arnaud M. Vigneron, Mario Campone

المساهمون: ISA NMR Methods for Metabolism - Methodes RMN en métabolomique (2014-2018), Institut des Sciences Analytiques (ISA), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Department of Medical Oncology [Lyon], Centre Léon Bérard [Lyon], Oncogénèse et progression tumorale, Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Pathologie mammaire, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Département d’Oncologie Médicale [Vandoeuvre Les Nancy], Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), UNICANCER-UNICANCER, Département de Sénologie, Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER-Université de Lille-UNICANCER, Institut Curie [Paris], UNICANCER, Centre de Recherche en Automatique de Nancy (CRAN), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Financial support from the IR-RMN-THC Fr3050 CNRS for conducting the research is gratefully acknowledged., Université Lille Nord de France (COMUE)-UNICANCER-Université Lille Nord de France (COMUE)-UNICANCER, Centre National de la Recherche Scientifique (CNRS)-Université de Lorraine (UL)

المصدر: Oncotarget
Oncotarget, 2017, 8 (48), pp.83570-83584. ⟨10.18632/oncotarget.18784⟩
Oncotarget, Impact journals, 2017, 8 (48), pp.83570-83584. ⟨10.18632/oncotarget.18784⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, mTOR inhibitor, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, 03 medical and health sciences, Breast cancer, Trastuzumab, [CHIM.ANAL]Chemical Sciences/Analytical chemistry, Internal medicine, Medicine, In patient, Protein translation, skin and connective tissue diseases, Preoperative treatment, Everolimus, business.industry, HER-2 positive breast cancer, medicine.disease, Serum samples, Discovery and development of mTOR inhibitors, metabolomics, targeted therapies, 3. Good health, Surgery, nuclear magnetic resonance, 030104 developmental biology, business, medicine.drug, Research Paper

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d87ddba4a521f9ff9995d1e3a51ea35Test
https://hal.science/hal-01646141Test

المؤلفون: Joanna Trelińska, Sergiusz Jozwiak, Katarzyna Kotulska, Wojciech Fendler, Iwona Dachowska, Wojciech Młynarski, Dobromila Baranska

المصدر: Pediatric Blood & Cancer. 62:616-621

مصطلحات موضوعية: medicine.medical_specialty, Everolimus, business.industry, medicine.medical_treatment, Urology, Hematology, Discovery and development of mTOR inhibitors, medicine.disease, Surgery, Tuberous sclerosis, Anticonvulsant, Oncology, Giant cell, Concomitant, Pediatrics, Perinatology and Child Health, medicine, Subependymal zone, business, PI3K/AKT/mTOR pathway, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::aa9b6b9872989c7e0984cf724ee27ae6Test
https://doi.org/10.1002/pbc.25368Test